Ghana Rejects $300M US Health Deal Over Data Privacy

Ghana recently joined other African nations in declining a major health partnership with the United States. This decision highlights growing health data privacy concerns across the continent. According to officials, the proposed deal lacked sufficient safeguards for sensitive citizen information. Consequently, Ghana has prioritized national data sovereignty over significant foreign funding.

Escalating Health Data Privacy Concerns in Negotiations

The proposed agreement was worth approximately $300 million over five years. However, the Ghanaian Data Protection Commission identified several legal and ethical breaches. Specifically, the deal would have granted up to 10 US entities access to national health datasets. Furthermore, these entities would not have needed prior approval from the Ghanaian government. Instead, the US would simply notify the country after data utilization. Therefore, officials argued that this arrangement effectively outsourced the nation's health architecture. Moreover, the scope of access extended beyond raw data to include dashboards and data models.

Regional Pushback on US Health Funding Terms

Ghana is the latest country to walk away from the \"America First\" global health funding model. For instance, Zimbabwe rejected a similar proposal earlier this year. Zambia is also currently reviewing sections of its draft agreement with significant skepticism. Activists claim these deals often lack adequate protections for pathogen and genomic information. Additionally, some agreements are viewed as overly restrictive regarding which healthcare providers receive support. As a result, the Africa CDC has expressed major concerns regarding international data sharing. Ghana now seeks improved terms that respect local governance and citizen privacy.

Frequently Asked Questions

Q1: Why did Ghana reject the US health agreement?

Ghana rejected the deal primarily due to health data privacy concerns. The agreement would have allowed foreign access to sensitive data without adequate local oversight or prior approval.

Q2: How much funding was involved in the rejected Ghana-US deal?

The deal was worth about $300 million total. It included $109 million in direct US funding over five years to fight diseases like malaria and HIV/AIDS.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. Ghana becomes the latest African country to reject a US health deal, citing datasharing concerns - ETHealthworld


2. Data Protection Commission of Ghana: Technical Assessment of the America First Global Health Strategy, 2026.


3. Africa Centres for Disease Control and Prevention: Report on International Data and Pathogen Sharing Agreements, 2026.